Aim To Cut Drug Prices By Asian Governments May Backfire, Discourage Investment – IMS
This article was originally published in PharmAsia News
Executive Summary
Efforts by Asian governments to reduce drug prices may have little impact on healthcare provision and may in fact backfire by driving some drugs out of the market.